Manufacturing processes rely heavily on organic solvents for cleaning, extraction, and material processing - yet residual solvents left on medical devices cause cytotoxicity, tissue irritation, and systemic toxicity that threaten patient safety while compromising regulatory compliance. Isopropyl alcohol (IPA) serves as one of the most common solvents in medical device manufacturing, used for cleaning assembled devices, dissolving adhesives, and facilitating material processing, making residual IPA testing fundamental to safety validation. IPA residual solvent analysis following ISO 10993-12 and ISO 10993-18 employs extraction in DMF (dimethylformamide) followed by quantitative GC-FID analysis, providing sensitive detection of residual IPA that could cause adverse biological responses through direct tissue contact or systemic absorption. The extraction methodology ensures complete IPA recovery from device surfaces and absorbed within materials, while GC-FID quantification delivers precise measurement enabling comparison against established safety limits derived from toxicological data and pharmacopeial standards. Critical for validating manufacturing cleaning processes demonstrating adequate IPA removal after solvent-based operations, supporting biocompatibility assessment per ISO 10993-1 where residual solvents contribute to extractables profiles, and ensuring compliance with ICH Q3C guidelines limiting residual solvents in medical devices and pharmaceutical products. For implantable devices and blood-contacting applications, even trace IPA residues pose risks through chronic exposure or direct systemic introduction, requiring validated analytical methods proving residual levels remain below acceptable limits throughout shelf life. The GC-FID approach provides solvent-specific quantification distinguishing IPA from other volatile compounds, supports process validation demonstrating consistent solvent removal across manufacturing lots, and enables investigation of unexpected cytotoxicity potentially linked to inadequate solvent removal. Manufacturing quality control uses IPA testing for batch release decisions ensuring products meet residual solvent specifications, validates that drying or aeration processes adequately remove IPA, and demonstrates that sterilization doesn't trap solvents within sealed packages.